Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

5α-reductases increase epitestosterone's effect on androgen receptors.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

New compounds may help treat prostate issues without affecting androgen receptors.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Compound 15a was effective in inhibiting 5α-reductase.

Marine sponges from Tabuhan Island can inhibit enzymes linked to Alzheimer's and hair loss.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5α-Reductase inhibitors can negatively impact sexual function.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.